Why the study?
Does a total CK activity threshold of 150 U/l safely rule out the need for CK-MB measurement in patients with suspected AMI?
Does a total CK activity threshold of 150 U/l safely rule out the need for CK-MB measurement in patients with suspected AMI?
Restricting CK-MB testing to patients with total CK activity > 150 U/l safely identifies AMI while potentially reducing unnecessary CK-MB measurements by 50%.
Answers are grounded in this paper and cite their sources.
May support limiting CK-MB testing to total CK >150 U/l in suspected AMI; leaves open need for prospective validation before practice change.
The purpose of this study was to establish a discriminatory limit for serum total creatine kinase activity (CK activity) below which CK isoenzyme fractionation is unnecessary. We looked at 2610 serum samples from 1077 consecutive patients with suspected acute myocardial infraction (AMI). The CK activity was determined according to the Scandinavian recommended method. Isoenzymes of CK were separated by agarose gel electrophoresis, followed by fluorometric scanning. When the threshold for CK activity was 150 U/l, none of the samples had a creatine kinase MB isoenzyme activity (CK-MB activity) equal to or higher than 30 U/l (the diagnostic level), which has been found to differentiate between patients with AMI and those without AMI. Only 14 patients (1.3% of all patients investigated) had CK-MB activity peaks between 10 U/l (detection limit) and 30 U/l. Of these, AMI was only diagnosed in one. We recommend that CK-MB activity should be measured only when CK activity is higher than 150 U/l. This would make about 50% of all CK-MB measurements unnecessary.
No takes yet. Share an insight, caveat, or question.
Knudsen et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: